Essential role of Na+/Ca2+ exchanger 1 in smoking-induced growth and migration of esophageal squamous cell carcinoma

• Published in: Oncotarget 2016-09, Vol.7 (39), p.63816-63828
• Main Authors: Wen, Jiexia, Pang, Yan, Zhou, Tao, Qi, Ximing, Zhao, Min, Xuan, Bin, Meng, Xiangcai, Guo, Yunsheng, Liu, Qingbin, Liang, Huagang, Li, Yang, Dong, Hui, Wang, Yimin
• Format: Article
• Language: English
• Subjects: Benzyl Compounds - chemistry; Calcium - metabolism; Carcinoma, Squamous Cell - metabolism; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial Cells - drug effects; Epithelial Cells - metabolism; Esophageal Neoplasms - metabolism; Esophageal Squamous Cell Carcinoma; Humans; Nitrosamines - adverse effects; Research Paper; Risk Factors; Smoking - adverse effects; Sodium - metabolism; Sodium-Calcium Exchanger - metabolism; Thiazolidines - chemistry; Thiourea - analogs & derivatives; Thiourea - chemistry; Tobacco Products
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.11695

Tobacco-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a major environmental risk factor for the pathogenesis of human esophageal squamous cell carcinoma (ESCC). However, the molecular mechanisms by which tobacco induces ESCC are not well understood. Na+/Ca2+ exchanger 1 (NCX1) is a plasma membrane transporter protein that plays an essential role in maintaining cytosolic Ca2+ ([Ca2+]cyt) homeostasis under physiological conditions and is implicated in tumorigenesis as well. In this study, we found that NCX1 expression was significantly higher in ESCC primary tissues compared to the noncancerous tissues and was overexpressed in tumor samples from the smoking patients. The expression of NCX1 proteins was also significantly higher in human ESCC cell lines compared to normal esophageal epithelial cell line. Moreover, NNK potentiated the [Ca2+]cyt signaling induced by removal of extracellular Na+, which was abolished by KB-R7943 or SN-6. NNK dose-dependently promoted proliferation and migration of human ESCC cells induced by NCX1 activation. Therefore, NCX1 expression correlates with the smoking status of ESCC patients, and NNK activates the Ca2+ entry mode of NCX1 in ESCC cells, leading to cell proliferation and migration. Our findings suggest NCX1 protein is a novel potential target for ESCC therapy.